Luminate Medical reposted this
Discover how Luminate Medical is revolutionising cancer treatment by reducing chemotherapy side effects and enabling at-home care. Read more about their latest innovations
Luminate Medical is a healthcare technology company that builds devices to make cancer care better for patients by preventing side effects and making at-home treatments a possibility. Based in Galway, Ireland, Luminate is pioneering the development of Lily, a device to prevent chemotherapy induced hair loss in a comfortable and portable way, Lilac, the world's first preventative treatment for peripheral neuropathy, and further pipeline projects enabling remote cancer care. Luminate is a VC-backed startup funded by Y Combinator (S21) with multiple successful grant and investment rounds to date.
External link for Luminate Medical
Galway, IE
Luminate Medical reposted this
Discover how Luminate Medical is revolutionising cancer treatment by reducing chemotherapy side effects and enabling at-home care. Read more about their latest innovations
Luminate Medical reposted this
ARTIS Ventures recently led a $15M Series A into Luminate Medical, led by Aaron Hannon. We're excited at their potential to transform the chemotherapy treatment process by reducing side effects for patients, lowering costs for payers, and unlocking value for private practice oncologists across the United States. Welcome to the Artis portfolio family!
Announcing the future of cancer treatment: delivering cancer therapies at home. Super excited to reveal Luminate Medical's $15m Series A led by ARTIS Ventures, with participation from Metaplanet, Lachy Groom and 8VC, alongside some excellent angel investors and our existing investors SciFounders and Faber. We're able to announce this funding off the back of successful clinical results using our technologies to prevent hair loss and peripheral neuropathy during chemotherapy. This round marks a big shift for Luminate: it allows us to pursue our vision of delivering cancer treatment at home. Building on our technologies to prevent the side effects of cancer treatment, we're working on new products to help deliver low-risk anti-cancer treatments and pre-treatment procedures outside of the clinic. We want to help patients spend more time at home, and physicians spend more time focused on high value procedures that make a real impact on patient outcomes. A huge thanks to our amazing team at Luminate: including founders Barbara Oliveira and Martin OHalloran, our fantastic management team Ellen Cahill, PhD, Aaron McCormack, EMMET FRAWLEY and newly added Conor Macken, and our super talented R&D, Clinical, Quality and Ops groups. I'm super lucky to work with all of you. Also a big thanks to everyone who has supported us, old and new - especially Matt Krisiloff, Alexander Schubert, Alexandre Barbosa, Sofia Santos, Niall McEvoy, Barry Regan, Austin Walne, Vasudev Bailey and so many more. There are too many to mention, but you know who you are! https://lnkd.in/ecDmn-CX
Luminate Medical reposted this
Luminate Medical (YC S21) has raised $15 million in Series A funding to make medical devices that stop the side effects of cancer treatment. Their first product, Lily, is a wearable cap that enables chemotherapy patients to prevent hair loss in a comfortable, portable way. The helmet applies even pressure on the scalp to block capillaries, stopping the harmful chemotherapy from reaching hair follicles. In initial tests, this method helped 75% of users keep their hair. "We’ve had patients finish four to 12 chemo treatments and keep a full head of hair. There’s been incredible feedback about how it’s changed their experience of going through treatment," said co-founder and CEO Aaron Hannon. The tests also showed that there were few, if any, safety, comfort, or device issues, and that wearing the helmet for longer actually improved outcomes. The next step is a multi-center study in the U.S. for FDA clearance. The team also found that pressure technology could help reduce chemo-induced neuropathy, which is nerve damage in the extremities. Their next medical device, Lilac, works like a precision compression sock or glove to provide more accurate and consistent pressure. It's the world's first device to prevent peripheral nerve damage caused by cancer treatment. Congrats Aaron, Barbara Oliveira, and the entire team at Luminate on the Series A! https://lnkd.in/gK8eJaJ4
Luminate Medical reposted this
If there is one thing you can say for Aaron Hannon, the chief executive of Luminate Medical, it is that he doesn’t lack ambition. “Our long term vision is that we want to deliver every cancer treatment at home, rather than in clinical settings as is typically the case now,” he says.
Luminate Medical is excited to announce our $15m Series A led by ARTIS Ventures, with participation from Metaplanet, Lachy Groom and 8VC. This funding will enable the company to move its Lily and Lilac devices, designed to prevent hair loss and peripheral neuropathy during chemo, towards FDA clearance, and add 30 new roles at our Galway HQ. https://lnkd.in/eGc4-Mze
The Luminate team has arrived at #ESMO24 - excited to be here and connect with oncologists, nurses, patient advocates to change the face of cancer care! Barbara Oliveira Cathy O'Boyle Gavin Reynolds
Congratulations to our very own Olivia Humphreys on her incredible achievement this week 👏
A Limerick woman has become the Irish regional finalist for the James Dyson Award after inventing a scalp-cooling device for chemotherapy patients. Olivia Humphreys (24) witnessed first hand how upsetting it is for patients who face losing their hair during chemotherapy when her mother Vicky went through it in 2019. 'Scalp-cooling treatment is a treatment that you can receive alongside your chemotherapy infusion and it aims to minimise hair loss,' Ms Humphreys said. 'Hair loss during chemotherapy is an extremely prominent issue and it's an incredibly upsetting thing to have to face when you're facing a diagnosis. My first goal was to increase the accessibility of the product,' she said. Ms Humphreys will now go to the international final stage of the James Dyson Award and the overall winner will be announced on November 13. Read more: https://buff.ly/4gm6SmH
We're hiring for a Senior R&D Engineer to work on our Lilac project! Funded by a €4.4M grant from Enterprise Ireland's DTIF program, Lilac aims to become the first FDA-approved technology to prevent the onset of peripheral nerve damage in chemotherapy patients.
We're #hiring again! We are looking for a Senior R&D Engineer to work on an exciting project here in Luminate Medical. Lilac is aimed at treating one of the most debilitating side effects of Chemotherapy, peripheral neuropathy. This is an opportunity to take your career to the next level and is a unique chance to work on the first generation of a device. If you are looking for a new challenge and want to have a real impact on the development of a new medical device then get in touch or apply at the link below!
Luminate Medical’s clinical team has been busy! Join Barbara Oliveira and Kimberly Wilkinson as they head to #ASCO24 in Chicago to keep exploring how to drive better #patientoutcomes and #qualityoflife for #cancer patients!
After a fantastic day at Dublin Tech Summit where we discussed the importance of innovation to drive better #patientoutcomes, we are now off to Chicago for this year’s American Society of Clinical Oncology (ASCO) Cancer Conference. Looking forward to learning more about our ever evolving field, and connecting with #patients, #oncologists, #trialists and #patientadvocates about improving #qualityoflife for #cancer #patients. Reach out to connect! #ASCO24 #ASCO2024 #chemotherapy #hairloss #sideeffects #medicaldevices
Join Luminate Medical's Co-Founder and Chief Clinical Officer Barbara Oliveira as she takes the stage tomorrow at the Dublin Tech Summit to discuss innovation for better patient outcomes, a core value behind Luminate's mission to help patients live better lives through cancer treatment!
Join us this week at the Dublin Tech Summit. On Thursday, our COO, Jean Redmond, will moderate the session titled "Innovating Change: HealthTech Solutions for Better Patient Outcomes," at 3:10 pm with Barbara Oliveira and Cristina Purtill. Looking forward to seeing you there! #DublinTechSummit #HealthTech #Innovation #PatientOutcomes #youcandobetterwithourAI